Characterization and Differential Diagnosis of Postneurosurgical Meningitis
Clinical Features, Microbiological Characteristics, and Differential Diagnosis of Postneurosurgical Meningitis
1 other identifier
observational
78
1 country
1
Brief Summary
Meningitis is a rare complication following neurosurgical procedures and is associated with high morbidity and mortality. The aim of this study is to describe the clinical characteristics and microbiological characteristics in patients who develope meningitis following neurosurgical operations, and investigate the useful tips for the differential diagnosis of postneurosurgical meningitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 11, 2010
CompletedFirst Posted
Study publicly available on registry
May 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedOctober 1, 2013
September 1, 2013
3.3 years
May 11, 2010
September 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development of meningitis
within 4 weeks after neurosurgical operation
Secondary Outcomes (1)
All-cause mortality
within 4 weeks after the diagnosis of meningitis
Eligibility Criteria
All patient who develop meningitis after neurosurgical operation
You may qualify if:
- Cerebrospinal fluid corrected WBC \>6/mm\^3 and/or fever (\> 38℃) and/or neck stiffness
You may not qualify if:
- Patients already treated more than 48 hours for meningitis before cerebrospinal fluid examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, 138-736, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sang-Ho Choi, MD
Asan Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 11, 2010
First Posted
May 13, 2010
Study Start
May 1, 2010
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
October 1, 2013
Record last verified: 2013-09